Federated Hermes Inc. Has $584,000 Position in Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Federated Hermes Inc. lessened its stake in shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) by 70.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 42,524 shares of the company’s stock after selling 99,160 shares during the period. Federated Hermes Inc.’s holdings in Bioceres Crop Solutions were worth $584,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of BIOX. Polar Capital Holdings Plc acquired a new position in shares of Bioceres Crop Solutions during the 3rd quarter worth about $2,112,000. Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of Bioceres Crop Solutions by 46.7% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 136,635 shares of the company’s stock worth $1,876,000 after buying an additional 43,484 shares during the last quarter. Ballast Asset Management LP acquired a new position in shares of Bioceres Crop Solutions during the third quarter worth approximately $2,210,000. Finally, Raymond James & Associates boosted its position in shares of Bioceres Crop Solutions by 4.9% in the third quarter. Raymond James & Associates now owns 27,567 shares of the company’s stock valued at $311,000 after acquiring an additional 1,300 shares during the period. Institutional investors own 17.68% of the company’s stock.

Analysts Set New Price Targets

Separately, Roth Mkm boosted their target price on shares of Bioceres Crop Solutions from $20.00 to $21.00 and gave the stock a “buy” rating in a research report on Friday, February 9th.

Bioceres Crop Solutions Stock Up 2.6 %

NASDAQ BIOX opened at $12.14 on Friday. Bioceres Crop Solutions Corp. has a twelve month low of $9.76 and a twelve month high of $14.20. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.84 and a current ratio of 1.24. The stock has a market cap of $762.36 million, a PE ratio of 37.94 and a beta of 0.63. The firm has a 50-day simple moving average of $12.63 and a 200 day simple moving average of $12.56.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its quarterly earnings data on Thursday, February 8th. The company reported $0.09 EPS for the quarter, topping analysts’ consensus estimates of $0.07 by $0.02. Bioceres Crop Solutions had a return on equity of 5.96% and a net margin of 4.36%. The company had revenue of $140.30 million during the quarter, compared to the consensus estimate of $108.97 million. During the same quarter last year, the company earned ($0.14) EPS. On average, research analysts forecast that Bioceres Crop Solutions Corp. will post 0.45 EPS for the current year.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.